More articles from Letter to the Editor

You have access
Response to Letter to the Editor on “Breast Cancer Resistance Protein (ABCG2) Determines Distribution of Genistein Phase II Metabolites: Reevaluation of the Roles of ABCG2 in the Disposition of Genistein”
Zhen Yang, Wei Zhu, Song Gao, Taijun Yin, Wen Jiang and Ming Hu

Drug Metabolism and Disposition November 2012, 40 (11) 2219-2220; DOI: https://doi.org/10.1124/dmd.112.048363
You have access
Reevaluation of the Roles of ABCG2 in the Disposition of Genistein
Ana I. Álvarez, Fernando Vallejo, Borja Barrera, Gracia Merino, Julio G. Prieto, Francisco Tomás-Barberán and Juan C. Espín

Drug Metabolism and Disposition November 2012, 40 (11) 2219; DOI: https://doi.org/10.1124/dmd.112.048140
You have access
Which CYP2B6 Variants Have Functional Consequences for Cyclophosphamide Bioactivation?
Nuala A. Helsby and Malcolm D. Tingle

Drug Metabolism and Disposition March 2012, 40 (3) 635-637; DOI: https://doi.org/10.1124/dmd.111.043646
You have access
Comment on “Permeability, Transport, and Metabolism of Solutes in Caco-2 Cell Monolayers: A Theoretical Study”
Yuan-Sheng Zhao, Zhe-Yi Hu, Rong-Rong Jiang, Jun-Ling Yang and Feng Chen

Drug Metabolism and Disposition March 2010, 38 (3) 534-535; DOI: https://doi.org/10.1124/dmd.109.030825
You have access
Response to Letter to the Editor on “Permeability, Transport, and Metabolism of Solutes in Caco-2 Cell Monolayers: A Theoretical Study”
Huadong Sun and K. Sandy Pang

Drug Metabolism and Disposition March 2010, 38 (3) 536-537; DOI: https://doi.org/10.1124/dmd.109.031195
You have access
The Time to Move Cytochrome P450 Induction into Mainstream Pharmacology Is Long Overdue
Dennis A. Smith, Maurice Dickins, Odette A. Fahmi, Kazuhide Iwasaki, Caroline Lee, R. Scott Obach, Guy Padbury, Sonia M. De Morais, Sharon L. Ripp, Jeff Stevens, Richard Voorman and Kuresh Youdim

Drug Metabolism and Disposition April 2007, 35 (4) 697-698; DOI: https://doi.org/10.1124/dmd.106.013284
You have access
Misuse of the Well-Stirred Model of Hepatic Drug Clearance
Jiansong Yang, Masoud Jamei, Karen R. Yeo, Amin Rostami-Hodjegan and Geoffrey T. Tucker

Drug Metabolism and Disposition March 2007, 35 (3) 501-502; DOI: https://doi.org/10.1124/dmd.106.013359
You have access
RESPONSE TO “BINDING OF DRUGS TO HEPATIC MICROSOMES: COMMENT AND ASSESSMENT OF CURRENT PREDICTION METHODOLOGY WITH RECOMMENDATION FOR IMPROVEMENT”
R. P. Austin, P. Barton and R. J. Riley

Drug Metabolism and Disposition April 2006, 34 (4) 727; DOI: https://doi.org/10.1124/dmd.105.009142
You have access
BINDING OF DRUGS TO HEPATIC MICROSOMES: COMMENT AND ASSESSMENT OF CURRENT PREDICTION METHODOLOGY WITH RECOMMENDATION FOR IMPROVEMENT
David Hallifax and J. Brian Houston

Drug Metabolism and Disposition April 2006, 34 (4) 724-726; DOI: https://doi.org/10.1124/dmd.105.007658
You have access
COMMENTS ON HOSKINS ET AL. [(2005) DRUG METAB DISPOS 33:1564–1565]
Andrea Gaedigk and J. Steven Leeder

Drug Metabolism and Disposition March 2006, 34 (3) 504-505; DOI: https://doi.org/10.1124/dmd.105.007799

Main menu

User menu

Search

More articles from Letter to the Editor

Pages

Navigate

More Information

ASPET's Other Journals